Flavio Aliberti

  https://medium.com/@flavalib Flavio Aliberti brings with him a 23-year track record in consulting around business intelligence, change management, strategy, M&A transformation, IT and SOX auditing for high regulated domains, like Insurance, Airlines, Trade Associations, Automotive, and Pharma. He holds an MSc in Space Aeronautic Engineering from the University of Naples and an MSc in Advanced Information Technology and Business Management from the University of Wales.

 



77 Stories by Flavio Aliberti

Pharma 2023: Navigating the Revolution of Integrated Supply Chains

Uncover the 2023 life science transformation towards an integrated supply chain, its potential, and challenges Pharmaceuticals are on the cusp of a revolution. The...
1 min read 201

Mastering Demand Planning for Big Pharma’s Future

Revolutionizing Supply Chain Efficiency: Unleashing the Power of Demand Planning, Technology, and Clinical Trials in the Pharmaceutical Industry The high-stakes world of pharmaceuticals isn’t...
3 min read 235

Drug Repurposing for Faster, Greener, and Affordable Treatments

Unlock drug repurposing potential: 10 facts on orphan drug acceleration & cost reduction in new treatments Imagine a world where we can tap into...
11 min read 296

Optimizing the Life Sciences Supply Chain through Network Visibility and Demand-Driven Planning

Explore life sciences supply chain optimization through network visibility, demand-driven planning, digital transformation, and coopetition Introduction: Embracing Digital Transformation and Coopetition The life sciences...
3 min read 389

5 Risks in Life Science M&A Transactions: Mitigation Strategies

Are you prepared to mitigate the top 5 risks in life science M&A transactions? Learn how now The life science business is continually developing and...
3 min read 251

Will United States of Care change the American healthcare system?

An in-depth look to approaches, challenges, and potential global influence to build a more inclusive society The American healthcare system has long been a...
4 min read 269

From Consumer Health to Cutting-Edge Therapies: The Decade in Review

M&A life science transactions can reveal trends and evolutionary patterns in the industry, and can lead to a new ecosystem The integration success between...
11 min read 234

Virtual Reality Therapy for Brain-Powered Healing

Explore how research on placebo and virtual reality will transforming healthcare and natural healing For decades, clinical researchers have been fascinated by the placebo effect....
3 min read 335

The Role of Visionary Leaders

Companies require more than just leadership that collects problems to be solved. Financial pragmatism erodes identity and suffocates innovation The Titusville Herald newspaper 23...
3 min read 291

Patients, Not Patents, Will Shape Life Science

Why M&A strategy focusing on selling low-margin business inhibits innovation, lowers entry barriers, dilutes expertise, and weakens patient ties In the last years, Mergers and...
3 min read 312

The Merger and Acquisition Shopping Experience

Digital improvements have transformed shoppers’ mindsets, and firms can use new best practices to buy or sell assets. Digital technology has made it simpler...
1 min read 302

The Persistent Failure Of Merger and Acquisition deals and why

M&A is not about transforming a company. It is about understanding what stays the same while everything else changes. Every day, we hear about a...
3 min read 665